Presentation TCT 2015

DAPT: A Prospective, Double-blind, Placebo-controlled Randomized Trial of 1-year Versus 2.5 Years of Dual Anti-platelet Therapy (Everolimus-Eluting Stent-Treated Subset)

Presenter: James B. Hermiller Jr

October 12, 2015

REGISTER for free or LOG IN to view this content

DAPT: A Prospective, Double-blind, Placebo-controlled Randomized Trial of 1-year Versus 2.5 Years of Dual Anti-platelet Therapy (Everolimus-Eluting Stent-Treated Subset)

Presentation

TCT 2015

Up Next

Presentation TCT 2015

PROMISE FFR-CT: Evaluation of FFR-CT in Patients Undergoing Computed Tomographic Angiography for Evaluation of Suspected Coronary Artery Disease

Presenter: Michael Lu

October 12, 2015

More slides +

Presentation TCT 2015

ABSORB III: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Vs. an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Presenter: Dean J. Kereiakes

October 12, 2015

Presentation TCT 2015

Should Every Referral for CABG Be Proceeded by Physiological Assessment?

Presenter: Erick Schampaert

October 12, 2015

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.